{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:58:47Z","timestamp":1790953127056,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of PR China","doi-asserted-by":"crossref","award":["81072695"],"award-info":[{"award-number":["81072695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of PR China","doi-asserted-by":"crossref","award":["91029746"],"award-info":[{"award-number":["91029746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangshu Province Natural Science Foundation","award":["BK 2010066"],"award-info":[{"award-number":["BK 2010066"]}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China (973 Program)","doi-asserted-by":"crossref","award":["2011CB505300-03"],"award-info":[{"award-number":["2011CB505300-03"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation for the Author of National Excellent Doctoral Dissertation of China","award":["200979"],"award-info":[{"award-number":["200979"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejphar.2013.09.024","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T15:16:14Z","timestamp":1379517374000},"page":"277-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver"],"prefix":"10.1016","volume":"721","author":[{"given":"Lifang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.09.024_bib1","series-title":"Milestones in Drug Therapy","first-page":"47","article-title":"Chemistry and biotransformation","author":"Abbott","year":"1999"},{"key":"10.1016\/j.ejphar.2013.09.024_bib2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2005.01748.x","article-title":"Recent concepts in non-alcoholic fatty liver disease","volume":"22","author":"Adams","year":"2005","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.ejphar.2013.09.024_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0883073809352888","article-title":"The effect of antiepileptic drugs on mitochondrial activity: a pilot study","volume":"25","author":"Berger","year":"2010","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.510230418","article-title":"Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions","volume":"23","author":"Booth","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.physbeh.2007.11.053","article-title":"Peroxisome proliferator-activated receptors and the metabolic syndrome","volume":"94","author":"Bragt","year":"2008","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.ejphar.2013.09.024_bib8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/dmd.108.024190","volume":"37","author":"Buckley","year":"2009","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib10","first-page":"128","article-title":"Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome","volume":"80","author":"Castro-Mart\u00ednez","year":"2012","journal-title":"Cirugia y Cirujanos"},{"key":"10.1016\/j.ejphar.2013.09.024_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/pgs.12.78","article-title":"Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid","volume":"13","author":"Chatzistefanidis","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2013.09.024_bib13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","article-title":"Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"68","author":"Chu","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100324","article-title":"Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects","volume":"83","author":"Chung","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.ejphar.2013.09.024_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.30.2.129","article-title":"UDP-glucuronosyltransferase mRNA levels in human liver disease","volume":"30","author":"Congiu","year":"2002","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03602530903209288","article-title":"Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system","volume":"42","author":"Court","year":"2010","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.ejphar.2013.09.024_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jhep.2012.07.003","article-title":"Phenotyping the effect of diet on non-alcoholic fatty liver disease","volume":"57","author":"de Wit","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-198903000-00002","article-title":"Urinary excretion of valproate and some metabolites in chronically treated patients","volume":"11","author":"Dickinson","year":"1989","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.ejphar.2013.09.024_bib19","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00216-009-3441-1","article-title":"Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies","volume":"396","author":"Donato","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.ejphar.2013.09.024_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/dmd.110.036608","article-title":"Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite","volume":"39","author":"Dostalek","year":"2011","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.008391","article-title":"Conserved valproic-acid-induced lipid droplet formation in dictyostelium and human hepatocytes identifies structurally active compounds","volume":"5","author":"Elphick","year":"2012","journal-title":"Disease Models and Mechanisms"},{"key":"10.1016\/j.ejphar.2013.09.024_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib23","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00645133","article-title":"Disposition of valproic acid in man","volume":"12","author":"Gugler","year":"1977","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/JPEM.2011.282","article-title":"The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children","volume":"24","author":"Gupta","year":"2011","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1016\/j.ejphar.2013.09.024_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.112.048439","article-title":"Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease","volume":"41","author":"Hardwick","year":"2013","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0731-7085(00)00491-X","article-title":"Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver micrososmes by HPLC with UV detection","volume":"25","author":"Hanioka","year":"2001","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.ejphar.2013.09.024_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2011.03328.x","article-title":"The influence of oral VPA on the required dose of propofol for sedation during dental treatment in patients with mental retardation: a prospective observer-blinded cohort study","volume":"53","author":"Ishii","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.09.024_bib31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.tiv.2010.03.014","article-title":"Participation of lipid transport and fatty acid metabolism in valproate sodium-induced hepatotoxicity in HepG2 cells","volume":"24","author":"Ji","year":"2010","journal-title":"Toxicology in Vitro"},{"key":"10.1016\/j.ejphar.2013.09.024_bib32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats: I. Toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib33","first-page":"251","article-title":"Comparison of stably expressed rat UGT1.1 and UGTB1 in the glucuronidation of opioid compounds","volume":"25","author":"King","year":"1996","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jep.2010.08.062","article-title":"The effect of bamboo extract on hepatic biotransforming enzymes\u2014findings from an obese-diabetic mouse model","volume":"133","author":"Koide","year":"2011","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib35","first-page":"845","article-title":"Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance","volume":"28","author":"Kumar","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib36","first-page":"S0168","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"28","author":"Leung","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.20074","article-title":"Valproate therapy and non-alcoholic fatty liver disease","volume":"55","author":"Luef","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/03602530903209544","article-title":"The regulation of UDP- glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors","volume":"42","author":"Mackenzie","year":"2010","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.ejphar.2013.09.024_bib39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/dmd.106.014225","article-title":"Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes","volume":"35","author":"Mano","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib40","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1210\/endo.141.11.7771","volume":"141","author":"Memon","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.105.004663","article-title":"An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity","volume":"33","author":"Miles","year":"2005","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/dmd.107.017731","article-title":"Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet","volume":"36","author":"Osabe","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03602530903208983","article-title":"Use of transgenic mice in UDP-glucuronosyltransferase (UGT) studies","volume":"42","author":"Ou","year":"2010","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.ejphar.2013.09.024_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2013.09.024_bib45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","article-title":"Structural and functional studies of UDP-glucuronosyltransferases","volume":"31","author":"Radominska-Pandya","year":"1999","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.ejphar.2013.09.024_bib46","first-page":"2010","article-title":"Peroxisome proliferator-activated receptor alpha target genes","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Research"},{"key":"10.1016\/j.ejphar.2013.09.024_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.ejphar.2013.09.024_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3923\/pjbs.2012.68.77","article-title":"Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy","volume":"15","author":"Saleh","year":"2012","journal-title":"Pakistan Journal of Biological Sciences"},{"key":"10.1016\/j.ejphar.2013.09.024_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/dmd.106.013243","article-title":"Expression of the human UGT1 locus in transgenic mice by 4-chloro-6- (2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation","volume":"35","author":"Senekeo-Effenberger","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.nut.2012.04.004","article-title":"Fetal programming of dietary fructose and saturated fat on hepatic quercetin glucuronidation in rats","volume":"28","author":"Serra","year":"2012","journal-title":"Nutrition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.31.3.326","article-title":"Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family","volume":"31","author":"Shelby","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib52","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1124\/dmd.106.010397","article-title":"Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways","volume":"34","author":"Shelby","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib53","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1124\/dmd.108.021469","article-title":"Species differences in UDP-glucuronosyltransferase activities in mice and rats","volume":"36","author":"Shiratani","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.ejphar.2013.09.024_bib56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of PPARs in NAFLD: potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.ejphar.2013.09.024_bib57","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2131\/jts.31.471","article-title":"Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators","volume":"31","author":"Tamura","year":"2006","journal-title":"Journal of Toxicological Sciences"},{"key":"10.1016\/j.ejphar.2013.09.024_bib58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2011.09.019","article-title":"Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice","volume":"257","author":"Tan","year":"2011","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.ejphar.2013.09.024_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/03602530903219220","article-title":"Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential","volume":"42","author":"Verreault","year":"2010","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.ejphar.2013.09.024_bib61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yebeh.2010.12.012","article-title":"Nonalcoholic fatty liver disease in adolescents receiving valproic acid","volume":"20","author":"Verrotti","year":"2011","journal-title":"Epilepsy and Behavior"},{"key":"10.1016\/j.ejphar.2013.09.024_bib62","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.phymed.2012.08.005","article-title":"Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells","volume":"15","author":"Vidyashankar","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2013.09.024_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2006.01.030","article-title":"Evaluation of mutation effects on UGT1A1 activity toward 17\u03b2-estradiol using liquid chromatography-tandem mass spectrometry","volume":"838","author":"Wada","year":"2006","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.ejphar.2013.09.024_bib64","doi-asserted-by":"crossref","unstructured":"Wakabayashi, N., Shin, S., Slocum, S.L., Agoston, E.S., Wakabayashi, J., Kwak, M.K., Misra, V., Biswal, S., Yamamoto, M., Kensler, T.W., 2010. Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Science Signaling 3, ra52.","DOI":"10.1126\/scisignal.2000762"},{"key":"10.1016\/j.ejphar.2013.09.024_bib65","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/dmd.109.031864","article-title":"Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential","volume":"38","author":"Wang","year":"2010","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib66","first-page":"95","article-title":"Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells","volume":"2","author":"Wei","year":"2010","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/j.ejphar.2013.09.024_bib67","doi-asserted-by":"crossref","DOI":"10.2133\/dmpk.DMPK-13-RG-020","article-title":"Dysregulations of intestinal and colonic UDP-glucuronosyltransferases in rats with type 2 diabetes","author":"Xie","year":"2013","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.ejphar.2013.09.024_bib68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/dmd.111.039925","article-title":"UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis","volume":"40","author":"Xu","year":"2012","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib69","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/dmd.105.006601","article-title":"Effect of chronic renal insufficiency on hepatic and renal udp-glucuronyltransferases in rats","volume":"34","author":"Yu","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.ejphar.2013.09.024_bib70","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1074\/jbc.M610790200","article-title":"Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice","volume":"282","author":"Yueh","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ejphar.2013.09.024_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients","volume":"37","author":"Zimmermann","year":"2003","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.ejphar.2013.09.024_bib72","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fct.2013.04.018","article-title":"Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH) via modulation of PPAR\u03b1 and SREBP-1","volume":"58","author":"Ziamajidi","year":"2013","journal-title":"Food and Chemical Toxicology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:38:35Z","timestamp":1588973915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913006778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":70,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0014299913006778"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}